A Prospective, Randomized Trial to Compare Mono-menotropins Protocol for Controlled Ovarian Stimulation (COS) Versus Recombinant Follicle Stimulating Hormone (rFSH) Protocol on Embryo Quality Parameters in IVF Patients

Trial Profile

A Prospective, Randomized Trial to Compare Mono-menotropins Protocol for Controlled Ovarian Stimulation (COS) Versus Recombinant Follicle Stimulating Hormone (rFSH) Protocol on Embryo Quality Parameters in IVF Patients

Recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Menotropin (Primary) ; Follitropin alfa
  • Indications Infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jun 2016 The protocol has been amended with the change of the comparator drug from Urofollitropin to Follitropin-alfa (Gonal-F) and hence the official title, purpose and treatment table has been amended.
    • 03 Jun 2016 Planned End Date changed from 1 Oct 2016 to 1 Jul 2017.
    • 03 Jun 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top